|
PRIMER |
UNIGENE CLUSTER I.D. |
GENE SYMBOL |
GENE DESCRIPTION |
| JS-1 |
Hs.292477 |
ETS2 |
V-ets erythroblastosis virus E26
oncogene homolog 2 |
| JS-2 |
Hs.77798 |
HARS |
Histidyl tRNA synthetase |
| JS-3 |
Hs.144906 |
METAP2 |
Methionyl aminopeptidase 2 |
| JS-4 |
Hs.317335 |
CLPP |
ClpP caseinolytic protease, ATP-dependent,
proteolytic subunit homolog (E. coli) |
| JS-5 |
Hs.82906 |
CDC20 |
CDC20 cell division cycle 20 homolog
(S. cerevisiae) |
| JS-6 |
Hs.82927 |
AMPD2 |
Adenosine monophosphate deaminase
2 (isoform L) |
| JS-10 |
Hs.355697 |
GLUD1 |
Glutamate dehydrogenase 1 |
| JS-12 |
Hs.436019 |
EVI1 |
Ecotropic viral integration site
1 |
| JS-13 |
Hs.30743 |
PRAME |
Preferentially expressed antigen
in melanoma |
| JS-15 |
Hs.18426 |
HRSP12 |
Heat-responsive protein 12 |
| JS-19 |
Hs.48516 |
B2M |
Beta-2-microglobulin |
| JS-23 |
Hs.351874 |
HLA-DOA |
Major histocompatibility complex,
class II, DO alpha |
| JS-25 |
Hs.404501 |
CDC2L5 |
Cell division cycle 2-like 5 (cholinesterase-related
cell division controller) |
| JS-29 |
Hs.449601 |
IGLJ3 |
Immunoglobulin lambda joining 3 |
| JS-30 |
Hs.103995 |
IGL@ |
Immunoglobulin heavy locus |
| JS-31 |
Hs.103995 |
IGL@ |
Immunoglobulin heavy locus |
| JS-33 |
Hs.232115 |
COL1A2 |
Collagen, type I, alpha 2 |
| JS-34 |
Hs.1478 |
SERPIND1 |
Serine (or cysteine) proteinase inhibitor,
clade D (heparin cofactor), member 1 |
| JS-35 |
Hs.62661 |
GBP1 |
Guanylate binding protein 1, interferon-inducible,
67kDa |
| JS-36 |
Hs.74823 |
ZNF183 |
Zinc finger protein 183 (RING finger,
C3HC4 type) |
| JS-37 |
Hs.407181 |
PRKCZ |
Protein kinase C, zeta |
| JS-41 |
Hs.231411 |
TBRG4 |
Transforming growth factor beta regulator
4 |
| JS-42 |
Hs.14623 |
IFI30 |
Interferon, gamma-inducible protein
30 |
| JS-43 |
Hs.129969 |
ELK4 |
ELK4, ETS-domain protein (SRF accessory
protein 1) |
| JS-44 |
Hs.437620 |
DOCK1 |
Dedicator of cytokinesis 1 |
| JS-45 |
Hs.97616 |
SH3GL1 |
SH3-domain GRB2-like 1 |
| JS-50 |
Hs.406693 |
UBE1 |
Ubiquitin-activating enzyme E1 (A1S9T
and BN75 temperature sensitivity complementing) |
| JS-55 |
Hs.173034 |
AMPH |
Amphiphysin (Stiff-Man syndrome with
breast cancer 128kDa autoantigen) |
| JS-56 |
Hs.178347 |
SKIP |
Skeletal muscle and kidney enriched
inositol phosphatase |
| JS-58 |
Hs.374650 |
IFITM3 |
Interferon induced transmembrane
protein 3 (1-8U) |
| JS-59 |
Hs.425144 |
CRA |
Cisplatin resistance associated |
| JS-61 |
Hs.26630 |
ABCA3 |
ATP-binding cassette, sub-family
A (ABC1), member 3 |
| JS-62 |
Hs.31210 |
BCL3 |
B-cell CLL/lymphoma 3 |
| JS-63 |
Hs.241567 |
RBMS1 |
RNA binding motif, single stranded
interacting protein 1 |
| JS-64 |
Hs.149846 |
ITGB5 |
Integrin, beta 5 |
| JS-65 |
Hs.192182 |
SYK |
Spleen tyrosine kinase |
| JS-66 |
Hs.430541 |
SON |
SON DNA binding protein |
| JS-68 |
Hs.78877 |
ITPKB |
Inositol 1,4,5-trisphosphate 3-kinase
B |
| JS-70 |
Hs.247302 |
TWSG1 |
Twisted gastrulation homolog 1 (Drosophila) |
| JS-71 |
Hs.440960 |
RAD23A |
RAD23 homolog A (S. cerevisiae) |
| JS-72 |
Hs.296380 |
POMZP3 |
POM (POM121 homolog, rat) and ZP3
fusion |
| JS-73 |
Hs.943 |
NK4 |
Natural killer cell transcript 4 |
| JS-76 |
Hs.511790 |
CLK3 |
CDC-like kinase 3 |
| JS-79 |
Hs.1708 |
CCT3 |
Chaperonin containing TCP1, subunit
3 (gamma) |
| JS-83 |
Hs.16530 |
CCL18 |
Chemokine (C-C motif) ligand 18 (pulmonary
and activation-regulated) |
| JS-85 |
Hs.446564 |
DDB2 |
Damage-specific DNA binding protein
2, 48kDa |
| JS-87 |
Hs.157307 |
GNAS |
GNAS complex locus |
| JS-88 |
Hs.25195 |
EBAF |
Endometrial bleeding associated factor |
| JS-91 |
Hs.295923 |
SIAH1 |
Seven in absentia homolog 1 (Drosophila) |
| JS-92 |
Hs.405667 |
CD8B1 |
CD8 antigen, beta polypeptide 1 (p37) |
| JS-93 |
Hs.77367 |
CXCL9 |
Chemokine (C-X-C motif) ligand 9 |
| JS-100 |
Hs.172816 |
NRG1 |
Neuregulin 1 |
| JS-101 |
Hs.114360 |
TGFB1I4 |
Transforming growth factor beta 1 induced transcript
4 |
| JS-103 |
Hs.315562 |
GCLM |
Glutamate-cysteine ligase, modifier subunit |
| JS-104 |
Hs.76095 |
IER3 |
Immediate early response 3 |
| JS-CL-96 |
Hs.75968 |
TMSB4X |
Thymosin, beta 4, X-linked |
| JS-CL-97 |
Hs.143873 |
S100A10 |
S100 calcium binding protein A10 (annexin II
ligand, calpactin I, light polypeptide (p11)) |
| JS-CL-99 |
Hs.413843 |
S100A2 |
S100 calcium binding protein A2 |
| JS-KS-1 |
Hs.82535 |
SLC6A12 |
Solute carrier family 6 (neurotransmitter transporter,
betaine/GABA), member 12 |
| JS-KS-2 |
Hs.410445 |
UNC119 |
Unc-119 homolog (C. elegans) |
| JS-KS-7 |
Hs.403997 |
VIL2 |
Villin 2 (ezrin) |
| JS-KS-8 |
Hs.211571 |
HCCS |
Holocytochrome c synthase (cytochrome c heme-lyase) |
| JS-KS-10 |
Hs.82399 |
COG2 |
Component of oligomeric golgi complex 2 |
| JS-KS-HK-2 |
Hs.441109 |
PEX19 |
Peroxisomal biogenesis factor 19 |
| JS-KS-HK-3 |
Hs.77798 |
HARS |
Histidyl-tRNA synthetase |
| JS-KS-HK-5 |
Hs.334874 |
PIK4CA |
Phosphatidylinositol 4-kinase, catalytic, alpha
polypeptide |
| JS-KS-12 |
Hs.350927 |
SLC25A6 |
Solute carrier family 25 (mitochondrial carrier;
adenine nucleotide translocator), member 6 |
| JS-KS-14 |
Hs.268530 |
GPS1 |
Transcribed sequence with moderate similarity
to protein pir:G01646 (H.sapiens) G01646 fusca protein homolog
Gps1 |
| JS-KS-19 |
Hs.635 |
CACNB1 |
Calcium channel, voltage-dependent, beta 1 subunit |
| JS-KS-3D |
Hs.96055 |
E2F1 |
E2F transcription factor 1 |
| JS-KS-6D |
Hs.31053 |
CKAP1 |
Cytoskeleton-associated protein 1 |
| JS-KS-11D |
Hs.356721 |
HNRPA1 |
Heterogeneous nuclear ribonucleoprotein A1 |
| JS-KS-13D |
Hs.80680 |
MVP |
Major vault protein |
| JS-KS-15D |
Hs.433326 |
IGFBP2 |
Insulin-like growth factor binding protein 2
(36kD) |
| JS-KS-17D |
Hs.172816 |
NRG1 |
Neuregulin 1 |
| JS-KS-18D |
Hs.364345 |
NNMT |
Nicotinamide N-methyltransferase |
| JS-KS-HK-1D |
Hs.75238 |
CHAF1B |
Chromatin assembly factor 1, subunit B (p60) |
| SB-4 |
Hs.21486 |
STAT1 |
Signal transducer and activator of transcription
1 |
| SB-6 |
Hs.407765 |
KPNA3 |
Karyopherin alpha 3 (importin alpha 4) |
| SB-8 |
Hs.204238 |
LCN2 |
Lipocalin 2 |
| SB-11 |
Hs.8765 |
DDX42 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
| SB-12 |
Hs.381099 |
LCP1 |
Lymphocyte cytosolic protein 1 (L-plastin) |
| JS-106 |
Hs.380684 |
CDS1 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) |
| JS-107 |
Hs.167741 |
BTN3A3 |
Butyrophilin, subfamily 3, member A3 |
| JS-112 |
Hs.505 |
ISL1 |
ISL1 transcription factor, LIM/homeodomain, (islet-1) |
| JS-115 |
Hs.443057 |
CD53 |
CD53 antigen |
| JS-116 |
Hs.439343 |
CAPN3 |
Calpain 3, (p94) |
| JS-120 |
Hs.439530 |
DYRK4 |
Dual-specificity tyrosine-(Y)-phosphorylation
regulated kinase 4 |
| JS-121 |
Hs.436852 |
FAP |
Fibroblast activation protein, alpha |
| JS-122 |
Hs.81071 |
ECM1 |
Extracellular matrix protein 1 |
| JS-125 |
Hs.7733 |
TTC1 |
Tetratricopeptide repeat domain 1 |
| JS-126 |
Hs.54451 |
LAMC2 |
Laminin, gamma 2 (nicein (100kD), kalinin (105kD),
BM600 (100kD), Herlitz junctional epidermolysis bullosa)) |
| JS-129 |
Hs.296169 |
RAB4A |
RAB4A, member RAS oncogene family |
| JS-131 |
Hs.179825 |
RANBP2L1 |
RAN binding protein 2-like 1 |
| JS-136 |
Hs.40403 |
CITED1 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich
carboxy-terminal domain, 1 |
| JS-143 |
Hs.439320 |
ITGA1 |
Integrin, alpha 1 |
| JS-149 |
Hs.343809 |
FGF12 |
Fibroblast growth factor 12 |
| JS-152 |
Hs.90458 |
SPTLC1 |
Serine palmitoyltransferase, long chain base
subunit 1 |
| JS-153 |
Hs.19236 |
NDUFB5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex,
5 (16kD, SGDH) |
| JS-156 |
Hs.411701 |
LGALS3 |
Lectin, galactoside-binding, soluble, 3 (galectin
3) |
| JS-158 |
Hs.348500 |
VIPR1 |
Vasoactive intestinal peptide receptor 1 |
| JS-159 |
Hs.80426 |
BRE |
Brain and reproductive organ-expressed (TNFRSF1A
modulator) |
| JS-163 |
Hs.121044 |
TAF1B |
TATA box binding protein (TBP)-associated factor,
RNA polymerase I, B, 63kD |
| JS-164 |
Hs.196669 |
EBP |
Emopamil-binding protein (sterol isomerase) |
| JS-HK-1 |
Hs.2795 |
LDHA |
Lactate dehydrogenase A |
| JS-HK-5 |
Hs.511899 |
EDN1 |
Endothelin 1 |
| JS-HK-7 |
Hs.289271 |
CYC1 |
Cytochrome c-1 |
| JS-HK-9 |
Hs.406277 |
SF3A1 |
Splicing factor 3a, subunit 1, 120kD |
| JS-HK-11 |
Hs.256184 |
EEF1G |
Eukaryotic translation elongation factor 1 gamma |
| JS-HK-13 |
Hs.26010 |
PFKP |
Phosphofructokinase, platelet |
| JS-HK-17 |
Hs.2178 |
H2BFQ |
H2B histone family, member Q |
| JS-HK-18 |
Hs.429180 |
EIF2S2 |
Eukaryotic translation initiation factor 2, subunit
2 (beta, 38kD ) |
| JS-166 |
Hs.256924 |
MAP2K6 |
Mitogen-activated protein kinase kinase 6 |
| JS-167 |
Hs.388921 |
PSMD2 |
Proteasome (prosome, macropain) 26S subunit,
non-ATPase, 2 |
| JS-168 |
Hs.381232 |
BCAP31 |
B-cell receptor-associated protein 31 |
| JS-169 |
Hs.283667 |
RNPEP |
Arginyl aminopeptidase (aminopeptidase B) |
| JS-170 |
Hs.381025 |
UBE2V1 |
Ubiquitin-conjugating enzyme E2 variant 1 |
| JS-171 |
Hs.432605 |
UGCG |
Ceramide glucosyltransferase |
| JS-172 |
Hs.409826 |
MGLL |
Monoglyceride lipase |
| JS-173 |
Hs.200738 |
SLC38A6 |
Solute carrier family 38, member 6 |
| JS-174 |
Hs.54673 |
TNFSF13 |
Tumor necrosis factor (ligand) superfamily, member
13 |
| JS-176 |
Hs.79137 |
PCMT1 |
Protein-L-isoaspartate (D-aspartate) O-methyltransferase |
| JS-177 |
Hs.77929 |
ERCC3 |
DNA repair helicase (ERCC3) |
| JS-179 |
Hs.334168 |
REPS2 |
RALBP1 associated Eps domain containing 2 |
| JS-180 |
Hs.519033 |
TLR2 |
Toll-like receptor 2 (TLR2) |
| JS-182 |
Hs.2256 |
MMP7 |
Matrix metalloproteinase 7 (matrilysin, uterine) |
| JS-183 |
Hs.270833 |
AREG |
Amphiregulin (schwannoma-derived growth factor) |
| JS-184 |
Hs.167700 |
SMAD5 |
SMAD, mothers against DPP homolog 5 |
| JS-188 |
Hs.512234 |
IL6 |
Interleukin 6 (B cell stimulatory factor 2) |
| JS-189 |
Hs.115263 |
EREG |
Epiregulin |
| JS-190 |
Hs.76224 |
EFEMP1 |
EGF-containing fibulin-like extracellular matrix
protein 1 |
| JS-192 |
Hs.409798 |
SGCE |
Sarcoglycan, epsilon |
| JS-193 |
Hs.24950 |
RGS5 |
Regulator of G-protein signalling 5 |
| JS-194 |
Hs.32963 |
CDH6 |
Cadherin 6, type 2, K-cadherin |
| JS-195 |
Hs.414795 |
SERPINE1 |
Serine (or cysteine) proteinase inhibitor, clade
E (nexin, plasminogen activator inhibitor type 1), member 1 |
| JS-197 |
Hs.496511 |
PRKCI |
Protein kinase C, iota |
| JS-199 |
Hs.278613 |
IFI27 |
Interferon, alpha-inducible protein 27 |
| JS-200 |
Hs.391392 |
ID4 |
Inhibitor of DNA binding 4, dominant negative
helix-loop-helix protein |
| JS-201 |
Hs.8136 |
EPAS1 |
Endothelial PAS domain protein 1 |
| JS-202 |
Hs.436836 |
MX1 |
Myxovirus (influenza) resistance 1, homolog of
murine (interferon-inducible protein p78) |
| JS-203 |
Hs.458485 |
G1P2 |
Interferon, alpha-inducible protein (clone IFI-15K) |
| JS-204 |
Hs.25960 |
MYCN |
V-myc avian myelocytomatosis viral related oncogene,
neuroblastoma derived |
| JS-205 |
Hs.79348 |
RGS7 |
Regulator of G-protein signalling 7 |
| JS-209 |
Hs.371468 |
CCND1 |
Cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
| JS-210 |
Hs.197805 |
SOX30 |
SRY (sex determining region Y)-box 30 |
| JS-211 |
Hs.861 |
MAPK3 |
Mitogen-activated protein kinase 3 |
| DA-1 |
Hs.1602 |
DPYD |
Dihydropyrimidine dehydrogenase |
| DA-2 |
Hs.165457 |
TK1 |
Thymidine kinase 1 |
| DA-3 |
Hs.87491 |
TYMS |
Thymidylate synthetase |
| JS-214 |
Hs.856 |
IFNG |
Interferon gamma |
| JS-215 |
Hs.1722 |
IL1A |
Interleukin 1, alpha |
| JS-217 |
Hs.388130 |
RNASET2 |
Ribonuclease T2 |
| JS-218 |
Hs.81791 |
TNFRSF11B |
Tumor necrosis factor receptor superfamily, member
11b (osteoprotegerin) |
| JS-220 |
Hs.74635 |
DLD |
Dihydrolipoamide dehydrogenase |
| JS-221 |
Hs.93913 |
IL6 |
Interleukin 6 |
| JS-250 |
Hs.412416 |
HIF1A |
Hypoxia-inducible factor 1 |
| JS-251 |
Hs.349845 |
PRKCB1 |
Protein kinase C, beta 1 |
| JS-252 |
Hs.83341 |
AXL |
AXL receptor tyrosine kinase |
| JS-253 |
Hs.149 |
CREB5 |
CAMP responsive element binding protein 5 |
| JS-256 |
Hs.211773 |
CHES1 |
Chromosome 14 open reading frame 116 |
| JS-259 |
Hs.155206 |
STK25 |
Serine/threonine kinase 25 (STE20 homolog, yeast) |
| JS-262 |
Hs.82002 |
EDNRB |
Endothelin receptor type B |
| JS-263 |
Hs.440960 |
RAD23A |
RAD23 homolog A |
| JS-264 |
Hs.279574 |
GRIM19 |
Cell death-regulatory protein GRIM19 |
| JS-265 |
Hs.279903 |
RHEB2 |
Ras homolog enriched in brain 2 |
| JS-266 |
Hs.96055 |
E2F1 |
E2F transcription factor 1 |
| JS-269 |
Hs.424619 |
PDCD10 |
Programmed cell death 10 |
| JS-270 |
Hs.379018 |
TFDP2 |
Transcription factor Dp-2 (E2F dimerization partner
2) |
| JS-271 |
Hs.77432 |
EGFR |
Epidermal growth factor receptor |
| JS-272 |
Hs.13340 |
HAT1 |
Histone acetyltransferase 1 |
| JS-273 |
Hs.72988 |
STAT2 |
Signal transducer and activator of transcription
2 |
| JS-274 |
Hs.1288 |
ACTA1 |
Actin, alpha 1, skeletal muscle |
| MM-1 |
Hs.351863 |
TST |
Thiosulfate sulfurtransferase (rhodanese) |
| MM-2 |
Hs.155281 |
PRKCE |
Protein kinase C, epsilon |
| JS-276 |
Hs.443831 |
PDCD5 |
Programmed cell death 5 |
| JS-277 |
Hs.279861 |
TMX2 |
Thioredoxin-related transmembrane protein 2 |
| JS-280 |
Hs.166994 |
FAT |
FAT tumor suppressor homolog 1 |
| JS-281 |
Hs.437638 |
XBP1 |
X-box binding protein 1 |
| JS-282 |
Hs.251574 |
SLBP |
Stem-loop (histone) binding protein |
| JS-286 |
Hs.439552 |
EEF1A1 |
Eukaryotic translation elongation factor 1 alpha
1 |
| JS-287 |
Hs.131736 |
NEDD5 |
Neural precursor cell expressed, developmentally
down-regulated 5 |
| JS-288 |
Hs.404814 |
VDAC1 |
Voltage-dependent anion channel 1 |
| JS-289 |
Hs.79081 |
PPP1CC |
Protein phosphatase 1, catalytic subunit, gamma
isoform |
| JS-290 |
Hs.32916 |
NACA |
Nascent-polypeptide-associated complex alpha
polypeptide |
| JS-295 |
Hs.5662 |
GNB2L1 |
Guanine nucleotide binding protein (G protein),
beta polypeptide 2-like 1 |
| JS-297 |
Hs.256184 |
EEF1G |
Eukaryotic translation elongation factor 1 gamma |
| JS-298 |
Hs.278573 |
CD59 |
CD59 antigen p18-20 |
| JS-301 |
Hs.275243 |
S100A6 |
S100 calcium-binding protein A6 (calcyclin) |
| JS-303 |
Hs.11638 |
ACSL5 |
Acyl-CoA synthetase long-chain family member
5 |
| JS-304 |
Hs.78888 |
DBI |
Diazepam binding inhibitor (GABA receptor modulator,
acyl-Coenzyme A binding protein) |
| JS-307 |
Hs.350927 |
SLC25A6 |
Solute carrier family 25 (mitochondrial carrier;
adenine nucleotide translocator), member 6 |
| JS-308 |
Hs.414985 |
GCLC |
Glutamate-cysteine ligase, catalytic subunit |
| JS-309 |
Hs.435981 |
ERCC1 |
Excision repair cross-complementing rodent repair
deficiency, complementation group 1 |
| JS-311 |
Hs.531561 |
EMP2 |
Epithelial membrane protein 2 |
| JS-312 |
Hs.78629 |
ATP1B1 |
ATPase, Na/K transporting, beta 1 polypeptide |
| JS-313 |
Hs.32949 |
DEFB1 |
Defensin, beta 1 |
| JS-316 |
Hs.624 |
IL8 |
Interleukin 8 |
| JS-319 |
Hs.114931 |
CTSH |
Cathepsin H |
| JS-321 |
Hs.387251 |
EVI5 |
Ecotropic viral integration site 5 |
| JS-322 |
Hs.86998 |
NFAT5 |
Nuclear factor of activated T-cells 5 |
| JS-323 |
Hs.371758 |
BCL7A |
B-cell CLL/lymphoma 7A |
| JS-324 |
Hs.173464 |
FKBP8 |
FK506-binding protein 8 (38kD) |
| JS-326 |
Hs.121575 |
CTSD |
Cathepsin D |
| JS-327 |
Hs.63984 |
CDH13 |
Cadherin-13, H-cadherin |
| JS-328 |
Hs.349109 |
IGF2 |
Insulin-like growth factor 2 (somatomedin A) |
| JS-330 |
Hs.417816 |
MAGEA3 |
Melanoma antigen, family A, 3 |
| JS-331 |
Hs.37107 |
MAGEA4 |
Melanoma antigen, family A, 4 |
| JS-334 |
Hs.311079 |
AATF |
Apoptosis antagonizing transcription factor |
| JS-335 |
Hs.36927 |
HSPH1 |
Heat shock 105kDa/110kDa protein 1 |
| JS-337 |
Hs.29499 |
TLR3 |
Toll-like receptor 3 |
| JS-338 |
Hs.406532 |
RPN2 |
Ribophorin II |
| JS-339 |
Hs.238990 |
CDKN1B |
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
| JS-342 |
Hs.437060 |
CYCS |
Cytochrome c |
| JS-343 |
Hs.343911 |
EI24 |
Etoposide-induced mRNA |
| JS-344 |
Hs.279869 |
MRPL28 |
Mitochondrial ribosomal protein L28 |
| JS-345 |
Hs.90436 |
SPAG7 |
Sperm associated antigen 7 |
| JS-349 |
Hs.96103 |
TAF5 |
TAF5 RNA polymerase II, TATA box binding protein
(TBP)-associated factor |
| JS350 |
Hs.308026 |
HLA-DRB3 |
Major histocompatibility complex, class II, DR
beta 3 |
| JS-352 |
Hs.50002 |
CCL19 |
Chemokine (C-C motif) ligand 19 |
| JS-353 |
Hs.57907 |
CCL21 |
Chemokine (C-C motif) ligand 21 |
| JS-354 |
Hs.73090 |
NFKB2 |
Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 2 (p49/p100) |
| JS-355 |
Hs.25647 |
FOS |
v-fos FBJ murine osteosarcoma viral oncogene
homolog |
| JS-356 |
Hs.305890 |
BCL2L1 |
BCL2-like 1 (bcl-xL) |
| JS-357 |
Hs.134106 |
MAP2K4 |
Mitogen-activated protein kinase kinase 4 |
| JS359 |
Hs.79428 |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein
3 |
| JS-360 |
Hs.11881 |
TM4SF4 |
Transmembrane 4 superfamily member 4 |
| JS-361 |
Hs.351316 |
TM4SF1 |
Transmembrane 4 superfamily member 1 |
| JS-362 |
Hs.442936 |
OAS1 |
2',5'-oligoadenylate synthetase 1, 40/46kDa |
| JS-365 |
Hs.270411 |
PLEKHC1 |
Pleckstrin homology domain containing, family
C (with FERM domain) member 1 |
| JS-366 |
Hs.150358 |
DPYSL3 |
Dihydropyrimidinase-like 3 |
| JS-367 |
Hs.76392 |
ALDH1A1 |
Aldehyde dehydrogenase 1 family, member A1 |
| JS-368 |
Hs.2704 |
GPX2 |
Glutathione peroxidase 2 |
| JS-369 |
Hs.512682 |
CEACAM1 |
Carcinoembryonic antigen-related cell adhesion
molecule 1 |
| JS-370 |
Hs.106620 |
NNT |
Nicotinamide nucleotide transhydrogenase |
| JS-376 |
Hs.159428 |
BAX |
BCL2-associated X protein |
| JS-377 |
Hs.114309 |
APOL1 |
Apolipoprotein L, 1 |
| JS-378 |
Hs.286221 |
ARF1 |
ADP-ribosylation factor 1 |
| JS-379 |
Hs.82502 |
POLD3 |
Polymerase (DNA directed), delta 3 |
| JS-380 |
Hs.288867 |
XPA |
Xeroderma pigmentosum, complementation group
A |
| JS-381 |
Hs.254406 |
ABT1 |
Activator of basal transcription 1 |
| JS-382 |
Hs.96103 |
TAF5 |
TAF5 RNA polymerase II, TATA box binding protein
(TBP)-associated factor |
| JS-383 |
Hs.149353 |
POLR2B |
Polymerase (RNA) II (DNA directed) polypeptide
B, 140kDa |
| JS-397 |
Hs.77311 |
BTG3 |
BTG family, member 3 |
| JS-400 |
Hs.32989 |
RAMP1 |
Receptor (calcitonin) activity modifying protein
1 |
| JS-401 |
Hs.204041 |
AHSA1 |
AHA1, activator of heat shock 90kDa protein ATPase
homolog 1 (yeast) |
| JS-405 |
Hs.353170 |
CALR |
Calreticulin |
| JS-406 |
Hs.202677 |
CD2BP2 |
CD2 antigen (cytoplasmic tail) binding protein
2 |
| JS-407 |
Hs.435811 |
ARRB2 |
Arrestin, beta 2 |
| JS-410 |
Hs.80285 |
ATF2 |
Activating transcription factor 2 |
| JS-420 |
Hs.171695 |
DUSP1 |
Dual specificity phosphatase 1 |
| JS-421 |
Hs.173043 |
MTA2 |
Metastais-associated gene family, member 2 |
| JS-422 |
Hs.77793 |
CSK |
C-src tyrosine kinase |
| JS-423 |
Hs.70327 |
CRIP2 |
Cysteine-rich protein 2 |
| JS-424 |
Hs.26458 |
MSRA |
Methionine sulfoxide reductase A |
| JS-431 |
Hs.147159 |
RNF103 |
Ring finger protein 103 |
| JS-435 |
Hs.1908 |
PRG1 |
Proteoglycan 1, secretory granule |
| JS-438 |
Hs.35052 |
TEGT |
Testis enhanced gene transcript (BAX inhibitor
1) |
| JS-443 |
Hs.155976 |
CUL4B |
Cullin 4B |
| JS-444 |
Hs.121576 |
MYO1B |
Myosin 1B |
| JS-445 |
Hs.7138 |
CHRM3 |
Cholinergic receptor, muscarinic 3 |
| JS-446 |
Hs.179565 |
MCM3 |
MCM3 minichromosome maintenance deficient 3 |
| JS-447 |
Hs.84318 |
RPA1 |
Replication protein A1, 70kDa |
| JS-448 |
Hs.109437 |
HUNK |
Hormonally upregulated Neu-associated kinase |
| JS-449 |
Hs.150956 |
EXTL1 |
Exostoses (multiple)-like 1 |
| JS-450 |
Hs.180930 |
BTAF1 |
BTAF1 RNA polymerase II, B-TFIID transcription
factor-associated, 170kDa |
| JS-452 |
Hs.272493 |
CCL15 |
Chemokine (C-C motif) ligand 15 |
| JS-455 |
Hs.254605 |
MAP7 |
Microtubule-associated protein 7 |
| JS-456 |
Hs.101382 |
TNFAIP2 |
Tumor necrosis factor, alpha-induced protein
2 |
| JS-459 |
Hs.422986 |
ANXA4 |
Annexin A4 |
| JS-460 |
Hs.295131 |
AKR1C1 |
Aldo-keto reductase family 1, member C1 (dihydrodiol
dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) |
| JS-461 |
Hs.78183 |
AKR1C3 |
Aldo-keto reductase family 1, member C3 (3-alpha
hydroxysteroid dehydrogenase, type II) |
| JS-462 |
Hs.201967 |
AKR1C2 |
Aldo-keto reductase family 1, member C2 (dihydrodiol
dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid
dehydrogenase, type III) |
| JS-464 |
Hs.368950 |
MEF2C |
MADS box transcription enhancer factor 2, polypeptide
C (myocyte enhancer factor 2C) |
| JS-465 |
Hs.414985 |
GCLC |
Glutamate-cysteine ligase, catalytic subunit |
| JS-466 |
Hs.441039 |
DKFZp686I15217 |
Hypothetical protein DKFZp686I15217 |
| JS-467 |
Hs.28988 |
GLRX |
Glutaredoxin (thioltransferase) |
| JS-468 |
Hs.406515 |
NQO1 |
NAD(P)H dehydrogenase, quinone (NQO1) |
| JS-470 |
Hs.441038 |
GAGEC1 |
G antigen, family C, 1 |
| JS-474 |
Hs.395309 |
TXN |
Thioredoxin |
| JS-478 |
Hs.86386 |
MCL1 |
Myeloid cell leukemia sequence 1 (BCL2-related) |
| JS-479 |
Hs.165439 |
ASNA1 |
ArsA arsenite transporter, ATP-binding, homolog
1 |
| JS-480 |
Hs.435541 |
TBCD |
Tubulin-specific chaperone d |
| JS-481 |
Hs.171695 |
DUSP1 |
Dual specificity phosphatase 1 |
| JS-483 |
Hs.321101 |
ATP9B |
ATPase, Class II, type 9B |
| JS-484 |
Hs.313 |
SPP1 |
Secreted phosphoprotein 1 (osteopontin) |
| JS-485 |
Hs.511917 |
ERCC4 |
Excision repair cross-complementing rodent repair
deficiency, complementation group 4 |
| JS-487 |
Hs.288867 |
XPA |
Xeroderma pigmentosum, complementation group
A |
| JS-488 |
Hs.77929 |
ERCC3 |
Excision repair cross-complementing rodent repair
deficiency, complementation group 3 (xeroderma pigmentosum group
B complementing) |
| JS-489 |
Hs.99987 |
ERCC2 |
Excision repair cross-complementing rodent repair
deficiency, complementation group 2 (xeroderma pigmentosum D) |
| JS-490 |
Hs.320 |
XPC |
Xeroderma pigmentosum, complementation group
C |
| AD-4 |
Hs.65425 |
CALB1 |
Calbindin 1, 28 kDa |
| AD-5 |
Hs.408543 |
MBP |
Myelin basic protein |
| AD-6 |
Hs.204238 |
LCN2 |
Lipocalin 2 (oncogene 24p3) |
| AD-7 |
Hs.76392 |
ALDH1A1 |
Aldehyde dehydrogenase 1 family, member A1 |
| AD-8 |
Hs.74034 |
CAV1 |
Caveolin 1, caveolae protein, 22kDa |
| AD-9 |
Hs.21330 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP),
member 1 |
| AD-10 |
Hs.503546 |
FADS1 |
Fatty acid desaturase 1 |
| AD-11 |
Hs.139851 |
CAV2 |
Caveolin 2 |
| AD-12 |
Hs.2256 |
MMP7 |
Matrix metalloproteinase 7 (matrilysin, uterine) |
| AD-13 |
Hs.442223 |
LSS |
Lanosterol synthase (2,3-oxidosqualene-lanosterol
cyclase) |
| AD-14 |
Hs.26630 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member
3 |
| JS-493 |
Hs.417004 |
S100A11 |
S100 calcium binding protein A11 (calgizzarin) |
| JS-495 |
Hs.31439 |
SPINT2 |
Serine protease inhibitor, Kunitz type, 2 |
| JS-501 |
Hs.372267 |
DDX24 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
| JS-505 |
Hs.8015 |
USP21 |
Ubiquitin specific protease 21 |
| JS-509 |
Hs.74563 |
OAZ2 |
Ornithine decarboxylase 2 |
| JS-511 |
Hs.308061 |
PAX8 |
Paired box gene 8 |
| JS-512 |
Hs.78065 |
C7 |
Complement component 7 |
| JS-515 |
Hs.372267 |
DDX24 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
| JS-516 |
Hs.420269 |
COL6A2 |
Collagen, type VI, alpha 2 |
| JS-517 |
Hs.75445 |
SPARCL1 |
SPARC-like 1 (mast9, hevin) |
| JS-520 |
Hs.69771 |
BF |
B-factor, properdin |
| JS-522 |
Hs.252820 |
PGF |
Placental growth factor, vascular endothelial
growth-related protein |
| JS-523 |
Hs.15432 |
DOC1 |
Downregulated in ovarian cancer 1 |
| JS-524 |
Hs.75335 |
GATM |
Glycine amidinotransferase (L-arginine:glycine
amidinotransferase) |
| JS-525 |
Hs.75445 |
SPARCL1 |
SPARC-like 1 (mast9, hevin) |
| JS-528 |
Hs.420269 |
COL6A2 |
Collagen, type VI, alpha 2 |
| JS-531 |
Hs.194657 |
CDH1 |
Cadherin 1, type 1, E-cadherin (epithelial) |
| JS-534 |
Hs.114412 |
TXNL1 |
Thioredoxin like, 32kda |
| JS-538 |
Hs.63788 |
PCCB |
Propionyl Coenzyme A carboxylase, beta polypeptide |
| JS-539 |
Hs.65425 |
CALB1 |
Calbindin 1, 28kDa |
| JS-542 |
Hs.84905 |
KRT20 |
Keratin 20 |
| JS-543 |
Hs.285313 |
COPEB |
Core promoter element binding protein |
| JS-544 |
Hs.35140 |
STK4 |
Serine/threonine kinase 4 |
| JS-545 |
Hs.89603 |
MUC1 |
Mucin 1, transmembrane |
| JS-546 |
Hs.407995 |
MIF |
Macrophage migration inhibitory factor (glycosylation-inhibiting
factor) |
| JS-550 |
Hs.324473 |
MAPK1 |
Mitogen-activated protein kinase 1 |
| JS-551 |
Hs.324473 |
MAPK1 |
Mitogen-activated protein kinase 1 |
| JS-555 |
Hs.436718 |
CEACAM6 |
Carcinoembryonic antigen-related cell adhesion
molecule 6 |
| JS-556 |
Hs.30942 |
EFNB2 |
Ephrin-B2 |
| JS-557 |
Hs.410037 |
CTGF |
Connective tissue growth factor |
| JS-559 |
Hs.376206 |
KLF4 |
Kruppel-like factor 4 (gut) |
| JS-561 |
Hs.237028 |
NPR3 |
Natriuretic peptide receptor C/guanylate cyclase
C (atrionatriuretic peptide receptor C) |
| JS-565 |
Hs.75652 |
GSTM5 |
Glutathione S-transferase M5 |
| JS-568 |
Hs.384598 |
SERPING1 |
Serine (or cystine) proteinase injhibitor, clade
G member 1 |
| JS-569 |
Hs.201776 |
PEG3 |
Paternally expressed 3 |
| JS-570 |
Hs.380833 |
IGFBP5 |
Insulin-like growth factor binding protein 5 |
| JS-572 |
Hs.105689 |
LTBP2 |
Latent transforming growth factor beta binding
protein 2 |
| JS-573 |
Hs.437351 |
CIRBP |
Cold Inducible RNA Binding Protein |
| JS-575 |
Hs.93765 |
LHFP |
Lipoma HMGIC fusion partner |
| JS-576 |
Hs.150276 |
CYP3A5 |
Cytochrome P450, family 3, subfamily A, polypeptide
5 |
| JS-577 |
Hs.150833 |
C4A |
Complement component 4A |
